Results 1 to 10 of about 983,966 (332)

National mass drug administration costs for lymphatic filariasis elimination. [PDF]

PLoS Neglected Tropical Diseases, 2007
BACKGROUND: Because lymphatic filariasis (LF) elimination efforts are hampered by a dearth of economic information about the cost of mass drug administration (MDA) programs (using either albendazole with diethylcarbamazine [DEC] or albendazole with ...
Ann S Goldman, Victoria H Guisinger, Moses Aikins, Maria Lourdes E Amarillo, Vicente Y Belizario, Bertha Garshong, John Gyapong, Conrad Kabali, Hussein A Kamal, Sanjat Kanjilal, Dominique Kyelem, Jefrey Lizardo, Mwele Malecela, Godfrey Mubyazi, P Abdoulaye Nitièma, Reda M R Ramzy, Thomas G Streit, Aaron Wallace, Molly A Brady, Richard Rheingans, Eric A Ottesen, Anne C Haddix   +21 more
doaj   +3 more sources

Cessation of Mass Drug Administration for Lymphatic Filariasis in Zanzibar in 2006: Was Transmission Interrupted? [PDF]

, 2015
BACKGROUND: Lymphatic filariasis (LF) is targeted for elimination through annual mass drug administration (MDA) for 4-6 years. In 2006, Zanzibar stopped MDA against LF after five rounds of MDA revealed no microfilaraemic individuals during surveys at ...
Maria P. Rebollo, Khalfan A. Mohammed, Brent Thomas, Shaali Ame, Said M. Ali, Jorge Cano, Alba Gonzalez Escalada, Moses J. Bockarie   +7 more
core   +19 more sources

Elimination of lymphatic filariasis: current perspectives on mass drug administration

Research and Reports in Tropical Medicine, 2018
John O Gyapong,1 Irene O Owusu,2 Frances B da-Costa Vroom,3 Ernest O Mensah,4 Margaret Gyapong5 1Centre for Neglected Tropical Diseases Research, Institute of Health Research, University of Health and Allied Sciences, Ho, 2Department of Epidemiology ...
Gyapong JO, Owusu IO, da-Costa Vroom FB, Mensah EO, Gyapong M   +4 more
doaj   +5 more sources

Feasibility and safety of mass drug coadministration with azithromycin and ivermectin for the control of neglected tropical diseases: a single-arm intervention trial [PDF]

The Lancet Global Health, 2018
Summary: Background: Mass drug administration has made a major contribution to the public health control of several important neglected tropical diseases.
Lucia Romani, PhD, Michael Marks, PhD, Oliver Sokana, MPH, Titus Nasi, MCH, Bakaai Kamoriki, Handan Wand, PhD, Margot J Whitfeld, FACD, Daniel Engelman, FRACP, Anthony W Solomon, FRCP, Andrew C Steer, ProfPhD, John M Kaldor, ProfPhD   +10 more
doaj   +4 more sources

Role of mass drug administration in elimination of Plasmodium falciparum malaria: a consensus modelling study [PDF]

The Lancet Global Health, 2017
Background: Mass drug administration for elimination of Plasmodium falciparum malaria is recommended by WHO in some settings. We used consensus modelling to understand how to optimise the effects of mass drug administration in areas with low malaria ...
Oliver J Brady, DPhil, Hannah C Slater, PhD, Peter Pemberton-Ross, PhD, Edward Wenger, PhD, Richard J Maude, MD, Prof Azra C Ghani, PhD, Melissa A Penny, PhD, Jaline Gerardin, PhD, Prof Lisa J White, PhD, Nakul Chitnis, PhD, Ricardo Aguas, PhD, Simon I Hay, DSc, Prof David L Smith, PhD, Erin M Stuckey, PhD, Emelda A Okiro, PhD, Prof Thomas A Smith, PhD, Dr Lucy C Okell, PhD   +16 more
doaj   +6 more sources

An evaluation of coverage and compliance of mass drug administration 2006 for elimination of lymphatic filariasis in endemic areas of Gujarat

Indian Journal of Community Medicine, 2008
Background: Mass drug administration (MDA) means once-in-a-year administration of diethyl carbamazine (DEC) tablet to all people (excluding children under 2 years, pregnant women and severely ill persons) in identified endemic areas.
Kumar Pradeep, Prajapati P, Saxena Deepak, Kavishwar Abhay, Kurian George   +4 more
doaj   +2 more sources

Lymphatic filariasis control in Tanzania: effect of six rounds of mass drug administration with ivermectin and albendazole on infection and transmission [PDF]

, 2013
Control of lymphatic filariasis (LF) in most countries of sub-Saharan Africa is based on annual mass drug administration (MDA) with a combination of ivermectin and albendazole, in order to interrupt transmission. We present findings from a detailed study
Paul E. Simonsen, Yahya A. Derua, William Kisinza, Stephen Magesa, Mwele Malecela, Erling M Pedersen   +5 more
openalex   +4 more sources

Evaluation of Triple Drug Administration for Lymphatic Filariasis in Prayagraj District, Uttar Pradesh, India: A Cross-sectional Study [PDF]

Journal of Clinical and Diagnostic Research, 2023
Introduction: Unplanned urbanisation and improper sanitary system in many cities in a developing country increase cases of vector borne diseases. Among these, filariasis is a major health problem in India.
Khurshid Parveen, Lal Divakar Singh
doaj   +1 more source

Community perceptions and acceptability of mass drug administration for the control of neglected tropical diseases in Asia-Pacific countries: A systematic scoping review of qualitative research

PLoS Neglected Tropical Diseases, 2022
Background Preventative chemotherapy and mass drug administration have been identified as effective strategies for the prevention, treatment, control and elimination of several NTDs in the Asia-Pacific region.
Elke Mitchell, Angela Kelly-Hanku, Alison Krentel, Lucia Romani, Leanne J. Robinson, Susana Vaz Nery, John Kaldor, Andrew C. Steer, Stephen Bell   +8 more
doaj   +3 more sources

Longitudinal Analysis of Antibody Responses to Trachoma Antigens Before and After Mass Drug Administration. [PDF]

, 2014
Blinding trachoma, caused by the bacteria Chlamydia trachomatis, is a neglected tropical disease targeted for elimination by 2020. A major component of the elimination strategy is mass drug administration (MDA) with azithromycin.
Dize, Laura, Gaydos, Charlotte, Goodhew, Erica Brook, Lammie, Patrick J, Martin, Diana L, Mkocha, Harran, Morgan, Sheri Maria, Munoz, Beatriz, Switzer, Andrew J, West, Sheila K, Wiegand, Ryan E   +10 more
core   +13 more sources